Vistin Pharma ASA (VISTN) — Cash Flow Reinvestment Rate
Vistin Pharma ASA (VISTN) has a Cash Flow Reinvestment Rate of 1.08x as of June 2025, reinvesting Nkr6.87 Million (capex Nkr3.43 Million plus investments Nkr-3.43 Million) from operating cash flow of Nkr6.37 Million. Explore VISTN capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Vistin Pharma ASA Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Vistin Pharma ASA across 6 annual periods. Also explore Vistin Pharma ASA balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Vistin Pharma ASA (2016–2024)
Year-by-year capital reinvestment analysis for Vistin Pharma ASA. For live market cap and broader valuation context, see Vistin Pharma ASA stock valuation.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.75x | Nkr81.10 Million | Nkr107.86 Million | Nkr40.80 Million | ▲ +91.4% |
| 2023 | 0.39x | Nkr35.58 Million | Nkr90.59 Million | Nkr17.90 Million | ▼ -91.6% |
| 2021 | 4.65x | Nkr63.62 Million | Nkr13.68 Million | Nkr31.94 Million | ▲ +139.8% |
| 2019 | 1.94x | Nkr36.71 Million | Nkr18.93 Million | Nkr18.36 Million | ▼ -88.4% |
| 2017 | 16.67x | Nkr158.48 Million | Nkr9.51 Million | Nkr35.55 Million | ▲ +2672.1% |
| 2016 | 0.60x | Nkr32.37 Million | Nkr53.84 Million | Nkr16.27 Million | — |